The therapeutic approach to hypoparathyroidism.
D000818:Animals; D000927:Anticonvulsants / Q000378:metabolism; D001711:Biotransformation; D003276:Contraceptives, Oral / Q000378:metabolism; D004032:Diet; D004097:Dihydrotachysterol / Q000627:therapeutic use; D004232:Diuretics / Q000378:metabolism; D004351:Drug Resistance; D004644:Emotions; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006934:Hypercalcemia / Q000139:chemically induced; D006996:Hypocalcemia / Q000139:chemically induced; D007011:Hypoparathyroidism / Q000097:blood / Q000188:drug therapy*; D008275:Magnesium Deficiency / Q000378:metabolism; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D013315:Stress, Psychological; D014149:Tranquilizing Agents / Q000378:metabolism; D014807:Vitamin D / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000927:Anticonvulsants; D003276:Contraceptives, Oral; D004232:Diuretics; D004967:Estrogens; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010710:Phosphates; D014149:Tranquilizing Agents; D014807:Vitamin D; D004097:Dihydrotachysterol